Noteworthy

Jan 31, 2017
As the healthcare landscape evolves, pharmaceutical companies are being driven to embrace new, unique partnerships to go beyond the pill, writes Weng Si Ho.
Jan 23, 2017
Pharmaceutical Executive
Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany’s healthcare business, shares her approach in transforming a traditional pharma unit focused on small molecules for chronic disease to a high-tech specialty producer of immunotherapy drugs for rare cancers.
Jan 18, 2017
Pharmaceutical Executive
With soaring valuations of companies in the public and M&A markets now a distant memory, the challenge for industry will be choosing the right mix of M&A, licensing, and partnering, writes Peter Young.
Jan 18, 2017
Pharmaceutical Executive
Connected ecosystems will change the future of healthcare. William King outlines three key value drivers.
Jan 17, 2017
Pharmaceutical Executive
Health reform, pricing pressures will shape drug marketing and development in 2017.
Dec 21, 2016
Pharmaceutical Executive
Cleveland Clinic looks at the big medical innovations in store for 2017.
Dec 18, 2016
Pharmaceutical Executive
In a continent marked by stark differences in governance, growth and market potential, the best bets must be pursued off script.
Dec 17, 2016
Pharmaceutical Executive
How a strong corporate board can help ignite success in these regions. By Christopher Burrows and Saule Serikova.
Dec 14, 2016
Pharmaceutical Executive
Pharm Exec sits down with veteran journalist Paula Apsell, the driving force behind the long-running PBS science series NOVA for some straightforward advice to the biopharma industry.
Dec 12, 2016
Bill Drummy reviews the "techno-optimistic" highlights of this year's Exponential Medicine conference in San Diego.
native1_300x100
lorem ipsum